NSETrading Window24 Jun 2026 · 24 Jun 2026, 10:01 pm
Trading Window
Krsnaa Diagnostics Limited · KRSNAA
✦ AI SummaryRegulatory
Krsnaa Diagnostics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from July 01, 2026, till the expiry of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending on June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krsnaa Diagnostics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
KRSNAA_24062026220142_543328.pdf
View document text
Date: June 24, 2026
Ref. No.: KDL/SE/019/2026-27
To, To,
BSE Limited National Stock Exchange of India Limited
Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G,
25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East)
Dalal Street, Mumbai- 400001 Mumbai – 400051
Scrip Code: 543328 NSE Symbol: KRSNAA
Dear Sir/Madam,
Subject: Intimation of closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations,
2015.
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (as
amended) and Company's ‘Code of Conduct to regulate, monitor and report trading by Designated
Persons’, the Trading Window for dealing in the securities of the Company shall remain closed from July
01, 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results of the Company
for the quarter ending on June 30, 2026.
All the Directors, Key Managerial Personnel, Designated Employees/persons, Promoters of the
Company and their immediate relatives are advised not to deal in the securities of the Company either
directly or indirectly during the aforesaid period.
The date of the Board Meeting of the Company for consideration and approval of the aforesaid results
will be intimated separately in due course.
You are requested to take the above information on your record.
For Krsnaa Diagnostics Limited
Sujoy Sudipta Bose
Company Secretary and Compliance Officer